Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
2.

Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine.

Sy LS, Meyer KI, Klein NP, Chao C, Velicer C, Cheetham TC, Ackerson BK, Slezak JM, Takhar HS, Hansen J, Deosaransingh K, Liaw KL, Jacobsen SJ.

Hum Vaccin Immunother. 2018 Feb 1;14(2):412-419. doi: 10.1080/21645515.2017.1403702. Epub 2017 Dec 14.

3.

Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology.

Velicer C, St Helen G, Glantz SA.

J Public Health Policy. 2018 Feb;39(1):34-48. doi: 10.1057/s41271-017-0096-6. Epub 2017 Nov 7.

4.

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.

Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, Muñoz N, Myers E, Paavonen J, Pitisuttihum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Papillomavirus Res. 2016 Dec;2:61-69. doi: 10.1016/j.pvr.2016.03.002. Epub 2016 Mar 14.

5.

Peer support of complex health behaviors in prevention and disease management with special reference to diabetes: systematic reviews.

Fisher EB, Boothroyd RI, Elstad EA, Hays L, Henes A, Maslow GR, Velicer C.

Clin Diabetes Endocrinol. 2017 May 25;3:4. doi: 10.1186/s40842-017-0042-3. eCollection 2017. Review.

6.

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience.

Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiNubile MJ, Lindsay BR, Kuter BJ, Perez G, Dominiak-Felden G, Saah AJ, Drury R, Das R, Velicer C.

Clin Infect Dis. 2016 Aug 15;63(4):519-27. doi: 10.1093/cid/ciw354. Epub 2016 May 26. Review.

7.

Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations.

Velicer C, Glantz SA.

PLoS One. 2015 Dec 30;10(12):e0142032. doi: 10.1371/journal.pone.0142032. eCollection 2015.

8.

9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.

Pitisuttithum P, Velicer C, Luxembourg A.

Expert Rev Vaccines. 2015;14(11):1405-19. doi: 10.1586/14760584.2015.1089174. Epub 2015 Sep 14. Review.

PMID:
26366475
9.

Tobacco companies' efforts to undermine ingredient disclosure: the Massachusetts benchmark study.

Velicer C, Aguinaga-Bialous S, Glantz S.

Tob Control. 2016 Sep;25(5):575-83. doi: 10.1136/tobaccocontrol-2015-052392. Epub 2015 Aug 20.

10.

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.

Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, Sings HL, Perez G, Haupt RM, Saah AJ, Lievano F, Velicer C, Drury R, Kuter BJ.

Pediatr Infect Dis J. 2015 Sep;34(9):983-91. doi: 10.1097/INF.0000000000000793. Review.

PMID:
26107345
11.

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008. doi: 10.1158/1055-9965.EPI-14-0410.

12.

Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.

Velicer C, Lempert LK, Glantz S.

Tob Control. 2015 Sep;24(5):469-80. doi: 10.1136/tobaccocontrol-2014-051571. Epub 2014 Jun 11.

13.

Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening.

Zhang SK, Ci PW, Velicer C, Kang LN, Liu B, Cui JF, Chen F, Zhang X, Chang IJ, Roberts CC, Smith JS, Chen W, Qiao YL.

Cancer Epidemiol. 2014 Apr;38(2):168-73. doi: 10.1016/j.canep.2014.01.004. Epub 2014 Feb 9.

PMID:
24522235
14.

Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study.

Zhang R, Velicer C, Chen W, Liaw KL, Wu EQ, Liu B, Cui JF, Belinson JL, Zhang X, Shen GH, Chen F, Qiao YL.

Cancer Epidemiol. 2013 Dec;37(6):939-45. doi: 10.1016/j.canep.2013.10.005. Epub 2013 Nov 8.

PMID:
24210584
15.

Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study.

Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, Niyazi M, Zhao C, Ren SD, Li CQ, Gong XZ, Smith JS, Belinson JL, Liaw KL, Velicer C, Qiao YL.

Cancer Causes Control. 2013 Apr;24(4):795-803. doi: 10.1007/s10552-013-0162-8. Epub 2013 Feb 9.

PMID:
23397310
16.

Safety of quadrivalent human papillomavirus vaccine administered routinely to females.

Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, Lewis N, Deosaransingh K, Sy L, Ackerson B, Cheetham TC, Liaw KL, Takhar H, Jacobsen SJ.

Arch Pediatr Adolesc Med. 2012 Dec;166(12):1140-8. doi: 10.1001/archpediatrics.2012.1451.

PMID:
23027469
17.

An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women.

Jacobsen SJ, Sy LS, Ackerson BK, Chao CR, Slezak JM, Cheetham TC, Takhar HS, Velicer CM, Hansen J, Klein NP.

Vaccine. 2012 Jun 29;30(31):4585-7. doi: 10.1016/j.vaccine.2012.04.103. Epub 2012 May 11.

PMID:
22580356
18.

Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.

Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Ackerson B, Cheetham TC, Hansen J, Deosaransingh K, Emery M, Liaw KL, Jacobsen SJ.

J Intern Med. 2012 Feb;271(2):193-203. doi: 10.1111/j.1365-2796.2011.02467.x. Epub 2011 Nov 15.

19.

Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort.

Brasky TM, Velicer CM, Kristal AR, Peters U, Potter JD, White E.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3185-8. doi: 10.1158/1055-9965.EPI-10-0942. Epub 2010 Oct 8.

20.

Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization.

Chao C, Velicer C, Slezak JM, Jacobsen SJ.

Am J Epidemiol. 2010 Feb 1;171(3):357-67. doi: 10.1093/aje/kwp365. Epub 2010 Jan 4.

21.

Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization.

Chao C, Velicer C, Slezak JM, Jacobsen SJ.

Mayo Clin Proc. 2009 Oct;84(10):864-70. doi: 10.1016/S0025-6196(11)60503-X.

22.

Prevalence and incidence of HPV genital infection in women.

Velicer C, Zhu X, Vuocolo S, Liaw KL, Saah A.

Sex Transm Dis. 2009 Nov;36(11):696-703. doi: 10.1097/OLQ.0b013e3181ad25ff.

PMID:
19652630
23.

Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.

Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML.

Gut. 2009 May;58(5):661-7. doi: 10.1136/gut.2007.144220. Epub 2008 Jun 3.

24.

Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.

Velicer CM, Ulrich CM.

J Clin Oncol. 2008 Feb 1;26(4):665-73. doi: 10.1200/JCO.2007.13.5905. Review.

PMID:
18235127
25.

NSAID use and breast cancer risk in the VITAL cohort.

Ready A, Velicer CM, McTiernan A, White E.

Breast Cancer Res Treat. 2008 Jun;109(3):533-43. Epub 2007 Aug 3.

PMID:
17674199
26.

Alcohol use and the risk of prostate cancer: results from the VITAL cohort study.

Velicer CM, Kristal A, White E.

Nutr Cancer. 2006;56(1):50-6.

PMID:
17176217
27.

Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.

Velicer CM, Dublin S, White E.

Prostate Cancer Prostatic Dis. 2007;10(1):46-51. Epub 2006 Oct 10.

PMID:
17033617
28.

Cimetidine use and the risk for prostate cancer: results from the VITAL cohort study.

Velicer CM, Dublin S, White E.

Ann Epidemiol. 2006 Dec;16(12):895-900. Epub 2006 Jul 12.

PMID:
16843010
29.

Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States).

Velicer CM, Heckbert SR, Rutter C, Lampe JW, Malone K.

Cancer Causes Control. 2006 Apr;17(3):307-13.

PMID:
16489538
30.

Antibiotic use in relation to the risk of breast cancer.

Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH.

JAMA. 2004 Feb 18;291(7):827-35.

PMID:
14970061
31.

Hypothesis: is antibiotic use associated with breast cancer?

Velicer CM, Lampe JW, Heckbert SR, Potter JD, Taplin SH.

Cancer Causes Control. 2003 Oct;14(8):739-47.

PMID:
14674738
32.

Managed care and primary physician satisfaction.

Grembowski D, Ulrich CM, Paschane D, Diehr P, Katon W, Martin D, Patrick DL, Velicer C.

J Am Board Fam Pract. 2003 Sep-Oct;16(5):383-93.

33.

Genetic testing for breast cancer: where are health care providers in the decision process?

Velicer CM, Taplin S.

Genet Med. 2001 Mar-Apr;3(2):112-9.

PMID:
11280948
34.

Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.

Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1381-5.

Supplemental Content

Loading ...
Support Center